Soliman, Paul S.
Curley, Dallece E.
Capone, Christy
Eaton, Erica
Haass-Koffler, Carolina L. http://orcid.org/0000-0002-5634-5679
Funding for this research was provided by:
NIH (R01 AA027760, R01 AA026589, R21 AA027614, P20 GM130414)
Article History
Received: 26 January 2024
Accepted: 22 April 2024
First Online: 29 April 2024
Declarations
:
: CLH-K received mifepristone and matching placebo for another trial and travel support to CA to present the data at the Corcept Therapeutic Conference (September 2022), holds two patents for the development of negative allosteric modulators targeting the stress system and one patent application on the development of a compound for noradrenergic blockade. All is unrelated to this work. The other authors declare no competing interests.